The Science Behind the Headlines

Search And Destroy: Chimeric Antigen Receptor T-Cells

Search And Destroy: Chimeric Antigen Receptor T-Cells

The first (and so far, only) chimeric antigen receptor T-cell (CAR-T) therapies—Kymriah (Novartis; Basel, Switzerland) and Yescarta—(Gilead; Foster City, CA) were approved in 2017, and remain one of the hottest immunotherapies on the market today. They work by...

read more

The free Biotech Primer WEEKLY explains the science behind today’s headlines. Delivered each Thursday directly to your inbox.

Subscribe to The WEEKLY today.

Blueprint Of The Century: DNA

Blueprint Of The Century: DNA

Please enjoy this excerpt from our recently revised book, The Biotech Primer: An Insider's Guide to the Science Driving the Biopharma Industry. This book explains the science behind the industry in an accessible manner, providing the foundation needed to understand...

read more

Biotech for Non-Scientists

Exosomes: Tiny Vesicles With Big Potential

Exosomes: Tiny Vesicles With Big Potential

Exosomes: Bio-trash to Bio-treasure We’ve all heard the phrase “One man’s trash is another man’s treasure.” It turns out that what often holds true for the antique business sometimes holds true for biotech as well. This WEEKLY shows how. Term of the Week: Exosome...

read more
An Egg-cellent Idea

An Egg-cellent Idea

An Egg-cellent Idea "The incredible, edible egg." This advertising slogan created for the American Egg Board in the 1970s rings truer than ever. Here’s why: scientists at the Roslin Institute (Midlothian, Scotland), part of the University of Edinburgh, recently...

read more

Medical Devices & Diagnostics

Getting The Jump On Alzheimer’s Disease

Getting The Jump On Alzheimer’s Disease

Getting The Jump On Alzheimer’s Disease Your dad has started losing his car keys, forgetting important dates, and even more alarming —is getting lost on the way to the grocery store. You’re thinking, “Is it Alzheimer’s?” Maybe it’s time for a trip to the doctor’s...

read more